Generic Name : Cholecalciferol Injection IP (Vitamin D3) Active Ingredient (per 1 ml ampoule) : Cholecalciferol IP — 6,00,000 IU (equivalent to 15 mg) Dosage Form & Strength : Form: Injectable solution (clear oil/solution) Strength: 6,00,000 IU Vitamin D3 per 1 ml ampoule Route of Administration : Intramuscular (IM) injection only Therapeutic Class: : Vitamin D3 supplement / Nutrient / Vitamin Mechanism of Action: : Cholecalciferol (Vitamin D3) helps the body absorb calcium and phosphorus, essential for bone mineralization and maintenance Packaging: : Usually supplied in 1 ml ampoules VITANOVA D3 6L Injection – Uses : Active ingredient: Cholecalciferol (Vitamin D3) – 6,00,000 IU per 1 ml Class: Vitamin supplement / Nutrient Form: Injectable solution (IM injection) Treatment of Vitamin D Deficiency : Corrects severe vitamin D deficiency in adults and children. Useful when oral supplementation is inadequate or not possible Management of Osteomalacia & Rickets : Osteomalacia: Softening of bones in adults due to lack of vitamin D. Rickets: Weak or deformed bones in children caused by vitamin D deficiency Support for Bone Health : Helps increase calcium and phosphorus absorption, supporting: Bone mineralization Prevention of fractures Overall skeletal health Special Situations : In patients with malabsorption syndromes (e.g., celiac disease, post-bariatric surgery). When rapid correction of vitamin D levels is needed under medical supervision Vitanova D3 6L Injection (600,000 IU of Cholecalciferol) is a high-dose vitamin D3 supplement used to treat severe vitamin D deficiency, osteoporosis, rickets, and osteomalacia (soft bones). It helps increase calcium and phosphate absorption from the gut, strengthening bones, improving immunity, and supporting cardiovascular health. Key Uses and Therapeutic Benefits : Severe Vitamin D Deficiency: Corrects critical shortages, often caused by malabsorption diseases of the gut, liver, or gallbladder. Bone Health (Rickets & Osteomalacia): Treats weak, soft, or brittle bones in both children and adults by enabling proper bone mineralization. Osteoporosis: Prevents the loss of bone density and reduces fracture risk, especially in post-menopausal women. Hypocalcemia: Manages low calcium levels in the blood, often linked to hypoparathyroidism. Immune System Support: Boosts immunity and increases resistance against various infections. How It Worksm : Vitamin D3 is converted in the liver and kidneys to its active form, calcitriol, which helps the intestines absorb calcium and phosphate, improving bone strength.

Active Ingredient : Nandrolone Decanoate USP – 250 mg per 1 ml injectable solution (oil-based). It is an anabolic–androgenic steroid (AAS). Dosage Form & Strength : Form: Injectable solution (typically oil). Strength: 250 mg of nandrolone decanoate per 1 ml ampoule/vial. Packaging: Usually supplied as 1 ml ampoules (often in packs like 10 × 1 ml). Pharmacological Class : Anabolic–androgenic steroid (AAS). Works by increasing protein synthesis and nitrogen retention, leading to anabolic effects (muscle/bone) Route of Administration : Deep intramuscular (IM) injection Active ingredient: Nandrolone Decanoate 250 mg/ml Class: Anabolic–androgenic steroid (AAS) Route: Deep intramuscular injection Treatment of Anemia (Certain Cases) : Used in some patients with: Chronic kidney disease–related anemia Aplastic anemia It helps stimulate red blood cell production. Osteoporosis (Postmenopausal Women – Selected Cases) : Helps improve bone density Reduces bone pain in osteoporosis Muscle Wasting Conditions : Used in certain medical situations such as: Chronic illness–related muscle loss Severe weight loss Recovery after major surgery or trauma It works by increasing protein synthesis and nitrogen retention. Decarix 250 mg Injection contains Nandrolone Decanoate, which is an anabolic steroid (a synthetic derivative of testosterone). It is primarily used to manage conditions requiring tissue repair and strengthening. Here are the main uses of Decarix 250 mg Injection : Osteoporosis in Post-menopausal Women: It is used to strengthen bones that have become thin, brittle, and fragile. Anemia Management: It helps manage certain types of severe anemia, particularly those associated with chronic kidney failure, by stimulating red blood cell production. Muscle Wasting Syndromes: It is used to combat muscle loss (cachexia) associated with chronic illnesses, including HIV/AIDS. Supportive Therapy: It may be used as an adjunct therapy for certain types of breast cancer and to offset muscle loss caused by long-term corticosteroid use.

Generic/Active Ingredient : Boldenone Undecylenate – 250 mg per 1 ml ampoule (250 mg/ml) Formulation : Sterile oil-based injectable solution Supplied in 1 ml ampoules Physical Form : Liquid injection (oil solution) Packaging : Typically 10 ampoules × 1 ml per pack Active ingredient: Boldenone Undecylenate 250 mg/ml (Class: Anabolic Androgenic Steroid – AAS) Boldenone undecylenate is mainly used in veterinary medicine, especially in horses and large animals for : Increasing appetite Promoting weight gain Improving muscle mass Supporting recovery after illness or surgery Treating debilitated or weak animals It works by stimulating protein synthesis and red blood cell production. BOLDARIX 250 MG INJ 1ML (containing Boldenone Undecylenate) is an anabolic-androgenic steroid, designed primarily for veterinary use (especially in horses) to promote weight gain, appetite, and muscle growth. It is important to note that its use in humans is often illegal, and it is largely utilized in the black market for bodybuilding.

Brand Name: Renocrit 4000 IU Injection Active Ingredient: Recombinant Human Erythropoietin Alfa (Epoetin alfa) – 4000 IU per dose Form: Injection (usually pre‑filled syringe of 0.4 ml) Drug Class: Erythropoiesis‑stimulating agent (ESA) Therapeutic Uses : Renocrit 4000 IU Injection is used to treat or manage anemia caused by: Chronic kidney disease (CKD) – including patients on dialysis or non‑dialysis. Anemia linked to cancer chemotherapy or cancer therapy. Anemia in patients treated with certain antiretroviral drugs (e.g., zidovudine for HIV). It may also be used to reduce the need for red blood cell transfusions before elective surgery in patients at high risk of blood loss. Administration : Route: Injected subcutaneously (under the skin) or intravenously (into a vein) under medical supervision. Dosage: Determined by a doctor based on body weight, hemoglobin levels, and response to treatment. (Active ingredient: Epoetin alfa 4000 IU per 0.4 ml) Main Uses : Anemia due to Chronic Kidney Disease (CKD) Helps increase red blood cell count in patients on dialysis or not on dialysis. Chemotherapy-Induced Anemia Used in cancer patients whose hemoglobin drops due to chemotherapy. HIV-Related Anemia For patients taking antiretroviral therapy (e.g., zidovudine) who develop low hemoglobin. Reduction of Blood Transfusions Pre-surgery or in conditions with expected high blood loss, to reduce the need for red blood cell transfusions. RENOCRIT 4000 IU Injection is a prescription medicine containing Epoetin alfa, used to treat anemia (low red blood cell count) caused by chronic kidney disease (both on and off dialysis), cancer chemotherapy, and HIV treatment (zidovudine). It stimulates bone marrow to produce more RBCs, reducing the need for blood transfusions. Key Uses and Indications : Chronic Kidney Disease (CKD) Anemia: Treats, prevents, or manages anemia in adult and pediatric patients with kidney failure. Cancer Chemotherapy-Induced Anemia: Helps raise hemoglobin levels in patients with non-myeloid malignancies. HIV-Associated Anemia: Manages anemia resulting from zidovudine therapy. Surgery Support: Reduces potential red blood cell transfusions in patients undergoing elective, non-cardiac, non-vascular surgery. How It Works : Renocrit contains a synthetic form of erythropoietin, a hormone that stimulates the bone marrow to produce red blood cells, helping improve oxygen transport and reduce symptoms of anemia. Stimulates the bone marrow to produce more red blood cells. Improves oxygen delivery to tissues and reduces symptoms like fatigue, weakness, and shortness of breath.

Brand / Product: Cefzone‑S 1.5 gm Injection Dosage form: Powder for injection — must be reconstituted before use. Strength: 1.5 g per vial (contains combination antibiotics) Composition : Active Ingredients per vial: Ceftriaxone 1000 mg — a third‑generation cephalosporin antibiotic Sulbactam 500 mg — a beta‑lactamase inhibitor that enhances the antibiotic’s effectiveness by preventing bacterial resistance Therapeutic Classification : Drug class: Antibiotic / Beta‑lactam combination Action: Ceftriaxone kills susceptible bacteria by interfering with their cell wall synthesis. Sulbactam inhibits beta‑lactamase enzymes produced by resistant bacteria, helping the antibiotic work better. Route & Administration : Route: Intravenous (IV) or Intramuscular (IM) injection — only healthcare professionals should administer. Preparation: Sterile water or suitable diluent added before injection. Key Uses and Indications : Respiratory Tract Infections: Treats pneumonia and bronchitis. Urinary Tract Infections (UTIs): Used for complex or resistant UTIs. Skin and Soft Tissue Infections: Treats infections like abscesses and cellulitis. Intra-abdominal Infections: Used for infections within the abdominal cavity. Meningitis: Effective against infections of the brain and spinal cord. Septicemia: Controls severe bloodstream infections. Surgical Prophylaxis: Administered to prevent infections before surgery. Cefzone‑S 1.5 g contains : Ceftriaxone 1 g – a third-generation cephalosporin antibiotic Sulbactam 0.5 g – a beta-lactamase inhibitor that enhances antibiotic activity It is a broad-spectrum antibiotic used for treating moderate to severe bacterial infections. Cefzone-S 1.5g Injection is a combination antibiotic (Ceftriaxone + Sulbactam) used to treat serious bacterial infections, including pneumonia, urinary tract infections, skin/soft tissue infections, meningitis, and intra-abdominal infections. It works by killing bacteria and stopping their growth. How It Works : Ceftriaxone: Kills bacteria by stopping cell wall formation. Sulbactam: Blocks bacterial beta-lactamase enzymes that can inactivate ceftriaxone, making the combination effective against resistant bacteria.

Brand / Product: Lox 2% Injection 30 ml Dosage Form: Injection (solution) Strength: 2% w/v (2 g of lidocaine per 100 ml = 20 mg/mL) — roughly 21.3 mg lidocaine per ml solution Pack Size: 30 ml vial Composition : Active Ingredient: Lidocaine (Lignocaine) Hydrochloride 2% — local anaesthetic agent Therapeutic Classification : Drug Class: Local anaesthetic Pharmacological Class: Amino amide type anaesthetic Route & Administration : Route: Intravenous (IV), intramuscular (IM), subcutaneous, or as part of a nerve block Physical Properties : Appearance: Clear, sterile, colourless solution Container: Sterile glass vial of 30 ml Lox 2% Injection is used to anesthetize or numb the surgical area during minor surgical procedures such as oral or dental. It is given as an injection under the supervision of a doctor. Minor injection site reactions (pain, swelling, redness) may occur for 1-2 minutes after injection. Lox 2% Injection contains Lidocaine (Lignocaine) Hydrochloride 2%, a local anaesthetic. Main Uses : Local Anaesthesia (Numbing) Used to numb a specific area before: Minor surgeries Suturing (stitches) Dental procedures Skin procedures Regional / Nerve Block Anaesthesia Blocks pain in a larger area by injecting near nerves. Used in : Orthopedic procedures Limb surgeries Spinal / Epidural Anaesthesia Used in certain surgical procedures (under specialist supervision). Cardiac Arrhythmias (IV Use) Used intravenously in hospitals to treat certain serious irregular heart rhythms (ventricular arrhythmias). How It Works : Blocks sodium channels in nerve cells. Prevents pain signals from reaching the brain. Acts quickly (within minutes).

Brand / Product: Augmed 1.2 G Injection Dosage form: Powder for injection (to be reconstituted) Pack size: 1 vial (single dose) Composition : Amoxycillin: 1000 mg (1 g) – a penicillin-type antibiotic Clavulanic Acid: 200 mg – a beta-lactamase inhibitor that prevents bacterial resistance and enhances amoxicillin action Therapeutic Classification : Class: Antibiotic combination – penicillin group Action: Broad-spectrum antibacterial action effective against many Gram-positive and Gram-negative bacteria For the treatment of bacterial infections of the sinus, ear, throat, lungs, airways, urinary tract, skin, soft tissue, bone, joints, abdomen, genitals, etc. Augmed 1.2 GM Injection – Uses : Augmed 1.2 GM Injection contains: Amoxicillin 1000 mg Clavulanic Acid 200 mg It is a broad-spectrum antibiotic injection used to treat moderate to severe bacterial infections. Main Uses : Respiratory Tract Infections Pneumonia Severe bronchitis Lung infections Ear, Nose & Throat (ENT) Infections Sinusitis Tonsillitis Severe throat infections Urinary Tract Infections (UTIs) Kidney infections Complicated UTIs Skin & Soft Tissue Infections Cellulitis Wound infections Abscesses Bone & Joint Infections Osteomyelitis Intra-abdominal Infections Peritonitis Post-surgical abdominal infections Gynecological Infections Pelvic infections Surgical Prophylaxis Given before surgery to prevent infection. How It Works : Amoxicillin kills bacteria by stopping cell wall formation. Clavulanic acid blocks beta-lactamase enzymes, preventing bacterial resistance and enhancing amoxicillin effectiveness.

Medicine Name: Human Mixtard 40 IU/ml Injection Form: Injectable suspension (vial) Pack Size: 10 ml vial Category: Antidiabetic insulin preparation used to manage blood glucose levels in diabetes mellitus. Composition : Active Ingredient: Human Insulin (recombinant) in a biphasic mix: short-acting soluble insulin and intermediate-acting isophane (NPH) insulin. The ratio varies by formulation (e.g., ~30% soluble + ~70% isophane). Preservatives: Includes metacresol and phenol (safe preservatives for insulin). Other: Aqueous suspension for injection. Therapeutic Class : Class: Human insulin (biphasic) Action: Provides both short-acting and intermediate-acting insulin for blood glucose control. Key Properties : Route of Administration: Subcutaneous injection (under the skin). Onset of Action: Short-acting component starts lowering blood glucose after injection. Duration: The intermediate-acting (isophane) component continues to lower blood glucose later, helping manage levels between meals and overnight. Storage: Keep refrigerated at 2–8 °C; do not freeze. Human Mixtard is a biphasic human insulin used to control blood sugar levels in diabetes mellitus. Main Uses : Type 1 Diabetes Mellitus Required for patients whose body does not produce insulin. Type 2 Diabetes Mellitus Used when oral antidiabetic medicines are not enough to control blood sugar. Gestational Diabetes (if prescribed by doctor) Helps control blood sugar during pregnancy when needed. Key Uses and Information : Diabetes Management: Treats both Type 1 and Type 2 diabetes. Blood Sugar Control: Provides both immediate (short-acting) and long-lasting (intermediate-acting) control. Administration: Administered under the skin, usually in the abdomen, thigh, or upper arm. Benefits : Maintains stable blood sugar levels Prevents diabetes complications (kidney damage, nerve damage, eye problems, heart disease) Suitable for twice-daily dosing in many patients HUMAN MIXTARD 40 IU 10ML is a combination of rapid-acting and intermediate-acting insulin used to treat Type 1 and Type 2 diabetes mellitus, helping control blood sugar levels. It acts by promoting glucose uptake by muscles/fat and suppressing sugar production in the liver. How It Works: : Human Mixtard contains: Short-acting insulin → Controls blood sugar after meals. Intermediate-acting (NPH) insulin → Controls blood sugar between meals and overnight. This combination provides both immediate and longer-lasting glucose control.

Generic Name: Tranexamic Acid Injection Brand (example): TRENAXA 500 mg Injection – 5 mL Form: Injectable solution (ampoule) Strength: 500 mg per 5 mL (i.e., 100 mg/mL) Route of Administration: Intravenous (IV) or intramuscular (IM) — administered slowly by a healthcare professional. Therapeutic Class: Anti‑fibrinolytic / Haemostatic agent (prevents excessive bleeding) Active Ingredient : Tranexamic Acid 500 mg per ampoule Tranexamic acid helps reduce the breakdown of fibrin (a key protein in blood clot formation), thereby supporting blood clot stability and reducing bleeding. Indications (Uses) : This injection is typically used for controlling or preventing abnormal or excessive bleeding in settings such as : Heavy menstrual bleeding Post‑surgical bleeding (dental, gynecologic, urologic, etc.) Nosebleeds (epistaxis) Bleeding associated with trauma or other bleeding disorders Conditions with excessive fibrinolysis (where clots break down too quickly) Administration & Precautions : Must be given by a healthcare professional; do not self‑inject. Injection is usually slow IV; intramuscular use depends on clinical judgment. Dose and frequency are determined by a doctor based on condition and patient factors. Stored typically below 25–30 °C and protected from direct light. Trenaxa injection is used to reduce excessive bleeding in menses (during periods). To treat abnormal blood loss during or after a surgical procedure. To reduce bleeding from the nose known as epistaxis. To control internal bleeding in the body due to abnormal blood clotting mechanism.